Please login to the form below

Not currently logged in
Email:
Password:

apceth names Ulrike Verzetnitsch as chief technical officer

She joins from Takeda, with immediate effect

edit-apceth-Ulrike-VerzetnischCell therapy company apceth has appointed Ulrike Verzetnitsch in the newly created role of chief technical officer.

In the position, Verzetnitsch will lead apceth's production facilities and operations and continue the expansion of its fee-for-service GMP manufacturing business.

Commenting on the appointment, Christine Guenther, CEO of apceth, said: “apceth has recently started phase II of the world's first clinical trial with genetically modified mesenchymal stem cells in cancer indications and is simultaneously increasing its manufacturing capacity and capabilities as a CMO. It is therefore a very exciting time for us to welcome Ulrike to the team.

“Her experience will complement our management team and help drive apceth forward.”

She joins from Takeda, where she was head of the production unit based in Singen, Germany. Prior to that, Verzetnitsch held the role of director of production at Baxter, where she focused on strategic tasks in the final container operation of vaccines and plasma-based and recombinant products.

As part of her role, she gained experience in the manufacturing of products for worldwide distribution in compliance with the FDA, EMEA, Japanese and other guidelines.

28th April 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics